nafamostat has been researched along with mocetinostat in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Murakami, K; Okabe, H; Okajima, K; Takatsuki, K; Uchiba, M | 1 |
| Inose, K; Komai, M; Naruse, T; Onai, M; Ono, K; Tsutida, A; Uehara, K; Yano, S | 1 |
| Boku, Y; Fujii, T; Hongo, H; Imai, A; Kondo, M; Naito, Y; Takano, H; Yamaguchi, T; Yoshida, N; Yoshikawa, T | 1 |
| Kistler, EB; Mitsuoka, H; Schmid-Schonbein, GW | 1 |
| Isaji, S; Takagi, K | 1 |
| Antoniu, BA; Balcom, JH; Fernández-del Castillo, CF; Keck, T; Lewandrowski, K; Warshaw, AL | 1 |
| Coimbra, R; Doucet, JJ; Hoyt, DB; Hugli, TE; Junger, WG; Loomis, WH; Paul L, W; Schmid-Schönbein, GW | 1 |
| Borawski, J | 1 |
| Jung, HC; Kim, YT; Lee, JK; Lee, SH; Park, JK; Ryu, JK; Yoon, WJ; Yoon, YB | 1 |
| Balejo, RD; Cortelli, JR; Cortelli, SC; Holzhausen, M; Lara, GM; Saad, WA | 1 |
| Ahn, JY; Cho, EY; Choi, SC; Im, LR; Kim, DK; Kim, JH; Kwon, SU; Lee, SH; Lee, YM; Xin, M | 1 |
| Andrade-Gordon, P; Barocelli, E; Cenac, N; Gobbetti, T; Martin, L; Motta, JP; Rolland, C; Steinhoff, M; Vergnolle, N | 1 |
| Altshuler, AE; Kim, GR; Penn, AH; Schmid-Schönbein, GW; Yang, JA | 1 |
1 review(s) available for nafamostat and mocetinostat
| Article | Year |
|---|---|
Myeloperoxidase as a marker of hemodialysis biocompatibility and oxidative stress: the underestimated modifying effects of heparin.
Topics: Anticoagulants; Atherosclerosis; Benzamidines; Biocompatible Materials; Biomarkers; Blood Vessels; Enzyme Activation; Guanidines; Heparin; Heparin, Low-Molecular-Weight; Humans; Membranes, Artificial; Neutrophils; Oxidative Stress; Peroxidase; Renal Dialysis; Thrombosis | 2006 |
1 trial(s) available for nafamostat and mocetinostat
| Article | Year |
|---|---|
Active inhibitory effect of nafamostat mesylate against the elevation of plasma myeloperoxidase during hemodialysis.
Topics: Adult; Aged; Antibodies, Monoclonal; Anticoagulants; Benzamidines; Female; Guanidines; Humans; Immunoenzyme Techniques; Leukocyte Count; Leukocyte Elastase; Male; Middle Aged; Neutrophils; Peroxidase; Renal Dialysis | 1997 |
12 other study(ies) available for nafamostat and mocetinostat
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
Topics: Animals; Benzamidines; Blood Vessels; Bronchoalveolar Lavage Fluid; Guanidines; Humans; Leukocyte Count; Lipopolysaccharides; Lung; Male; Neutrophils; Peroxidase; Rats; Rats, Wistar; Serine Proteinase Inhibitors; Tumor Necrosis Factor-alpha | 1997 |
Pancreatic phospholipase A2 induces bacterial translocation in rats.
Topics: Acute Disease; Animals; Bacterial Translocation; Benzamidines; Cecum; Guanidines; Injections, Intraperitoneal; Lymph Nodes; Male; Mesentery; Pancreas; Pancreatitis; Peroxidase; Phospholipases A; Phospholipases A2; Protease Inhibitors; Rats; Rats, Sprague-Dawley | 1999 |
Generation of in vivo activating factors in the ischemic intestine by pancreatic enzymes.
Topics: Animals; Benzamidines; Bile; Blood Pressure; Guanidines; Intestinal Mucosa; Intestines; Ischemia; Leukocytes; Liver; Lung; Male; Pancreas; Peroxidase; Protease Inhibitors; Rats; Rats, Wistar; Serine Endopeptidases; Shock; Trypsin | 2000 |
Therapeutic efficacy of continuous arterial infusion of an antibiotic and a protease inhibitor via the superior mesenteric artery for acute pancreatitis in an animal model.
Topics: Acute Disease; Amylases; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Benzamidines; Bile; Disease Models, Animal; Dogs; Female; Guanidines; Imipenem; Infusions, Intra-Arterial; Intestinal Mucosa; Male; Mesenteric Artery, Superior; Microscopy, Electron, Scanning; Pancreas; Pancreatitis; Peroxidase; Protease Inhibitors; Thienamycins | 2000 |
Regional effects of nafamostat, a novel potent protease and complement inhibitor, on severe necrotizing pancreatitis.
Topics: Animals; Benzamidines; Capillary Permeability; Complement Inactivator Proteins; Evans Blue; Gabexate; Guanidines; Injections, Intra-Arterial; Injections, Intravenous; Lung; Male; Oligopeptides; Pancreas; Pancreatitis, Acute Necrotizing; Peritoneum; Peroxidase; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors; Survival Rate | 2001 |
Inhibition of enteral enzymes by enteroclysis with nafamostat mesilate reduces neutrophil activation and transfusion requirements after hemorrhagic shock.
Topics: Animals; Benzamidines; Blood Transfusion; Electrolytes; Enema; Guanidines; Intestinal Mucosa; Intestine, Small; Liver; Lung; Male; Neutrophil Activation; Peroxidase; Polyethylene Glycols; Protease Inhibitors; Shock, Hemorrhagic; Swine; Systemic Inflammatory Response Syndrome | 2004 |
Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
Topics: Amylases; Animals; Benzamidines; Ceruletide; Female; Guanidines; Interleukin-6; Lipase; Mice; Mice, Inbred BALB C; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Peroxidase; Protease Inhibitors | 2008 |
Nafamostat mesilate, a potent tryptase inhibitor, modulates periodontitis in rats.
Topics: Alveolar Bone Loss; Animals; Benzamidines; Benzoylarginine Nitroanilide; Cell Movement; Chromogenic Compounds; Gingiva; Gingivitis; Granulocytes; Guanidines; Male; Mandibular Diseases; Molar; Peptide Hydrolases; Periodontitis; Peroxidase; Random Allocation; Rats; Rats, Wistar; Receptor, PAR-2; Time Factors; Trypsin Inhibitors; Tryptases | 2011 |
Nafamostat mesilate attenuates colonic inflammation and mast cell infiltration in the experimental colitis.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamidines; Blotting, Western; Cell Count; Chymases; Colitis; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Guanidines; Immunity, Mucosal; Intestinal Mucosa; Mast Cells; Mice; Mice, Inbred BALB C; Peroxidase | 2011 |
Serine protease inhibition reduces post-ischemic granulocyte recruitment in mouse intestine.
Topics: alpha-Macroglobulins; Animals; Benzamidines; Chemokines; Cysteine Proteinase Inhibitors; Granulocytes; Guanidines; Intestine, Small; Ischemia; Leucine; Male; Mice; Mice, Inbred C57BL; Peroxidase; Protease Inhibitors; Receptor, PAR-1; Receptor, PAR-2; Reperfusion Injury; Serine Proteinase Inhibitors; Trypsin | 2012 |
Protease activity increases in plasma, peritoneal fluid, and vital organs after hemorrhagic shock in rats.
Topics: Animals; Ascitic Fluid; Benzamidines; Body Fluids; Brain; Guanidines; Immunoblotting; Liver; Lung; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Myocardium; Peritoneal Cavity; Peroxidase; Rats; Rats, Wistar; Serine Proteases; Serine Proteinase Inhibitors; Shock, Hemorrhagic; Substrate Specificity; Trypsin | 2012 |